CYTOXAN: CYCLOPHOSPHAMIDE FOR INJECTION.
The CYCLOPHOSPHAMIDE FOR INJECTION is a the manufacturer industrial component. Key specifications include physical_form: FREEZE-DRIED POWDER, special_features: C/O 375 MG MANNITOL; VIAL WITH ADEQUATE VOLUME TO ALLOW ADDITION OF 25 ML OF DILUENT AND ADEQUATE SHAKE SPACE, features_provided: CHILD RESISTANT CLOSURE, primary_container_type: BOTTLE, protective_storage_feature: ANTINEOPLASTIC DRUG, medical_designation_and_grade: UNITED STATES PHARMACOPEIA. This part is cataloged in the U.S.
Government catalog under NSN 6505-00-733-5246, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.
Verify compatibility with your specific system configuration before ordering.
| physical_form | FREEZE-DRIED POWDER |
| special_features | C/O 375 MG MANNITOL; VIAL WITH ADEQUATE VOLUME TO ALLOW ADDITION OF 25 ML OF DILUENT AND ADEQUATE SHAKE SPACE |
| features_provided | CHILD RESISTANT CLOSURE |
| primary_container_type | BOTTLE |
| protective_storage_feature | ANTINEOPLASTIC DRUG |
| medical_designation_and_grade | UNITED STATES PHARMACOPEIA |
| warning_and_caution_statements | CHEMOTHERAPEUTIC AGENT; HANDLE WITH CARE |
| total_primary_container_quantity | 6 |
| primary_container_content_quantity | 100.000 TABLETS |
| active_medicament_medicinal_strength | 25.000 MILLIGRAMS CYCLOPHOSPHAMIDE ACTIVE INGREDIENT |
| part_name_assigned_by_controlling_agency | CYCLOPHOSPHAMIDE TABLETS USP 25ML 100S BT |
| NSN | 6505-00-733-5246 |
| PRIMARY CONTAINER CONTENT QUANTITY | 100.000 TABLETS |
| MEDICAL DESIGNATION AND GRADE | UNITED STATES PHARMACOPEIA |
| PRIMARY CONTAINER TYPE | BOTTLE |
| SPECIAL FEATURES | ANHYDROUS CYCLOSPHAMIDE ACTIVE INGREDIENT |
| PROTECTIVE STORAGE FEATURE | ANTINEOPLASTIC DRUG |
| PART NAME ASSIGNED BY CONTROLLING AGENCY | CYCLOPHOSPHAMIDE TABLETS USP 50 MG 100S |
| ACTIVE MEDICAMENT MEDICINAL STRENGTH | 50.000 MILLIGRAMS CYCLOPHOSPHAMIDE ACTIVE INGREDIENT |
No substitute or cross-reference records for this part.